Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionpattern recognition receptor activity

IFIH1 PGLYRP1

9.45e-0435262GO:0038187
GeneOntologyMolecularFunctionDNA-binding transcription factor activity, RNA polymerase II-specific

NR4A2 USF3 IKZF3 ZNF229 ZNF560 ZFHX4 YLPM1

1.73e-031412267GO:0000981
Domainzf-C2H2

ZNF462 POGZ IKZF3 ZNF229 ZNF560 ZFHX4

1.94e-04693246PF00096
DomainZINC_FINGER_C2H2_2

ZNF462 POGZ IKZF3 ZNF229 ZNF560 ZFHX4

3.55e-04775246PS50157
DomainZINC_FINGER_C2H2_1

ZNF462 POGZ IKZF3 ZNF229 ZNF560 ZFHX4

3.60e-04777246PS00028
DomainZnf_C2H2-like

ZNF462 POGZ IKZF3 ZNF229 ZNF560 ZFHX4

4.09e-04796246IPR015880
DomainZnf_C2H2

ZNF462 POGZ IKZF3 ZNF229 ZNF560 ZFHX4

4.35e-04805246IPR007087
DomainZnF_C2H2

ZNF462 POGZ IKZF3 ZNF229 ZNF560 ZFHX4

4.43e-04808246SM00355
Domain-

ZNF462 IKZF3 ZNF229 ZNF560 ZFHX4

1.50e-036792453.30.160.60
DomainZnf_C2H2/integrase_DNA-bd

ZNF462 IKZF3 ZNF229 ZNF560 ZFHX4

1.65e-03694245IPR013087
DomainKRAB

ZNF229 ZNF560 ZNF783

1.05e-02358243PS50805
DomainKRAB

ZNF229 ZNF560 ZNF783

1.05e-02358243PF01352
DomainKRAB

ZNF229 ZNF560 ZNF783

1.14e-02369243SM00349
DomainKRAB

ZNF229 ZNF560 ZNF783

1.15e-02370243IPR001909
Pubmed

A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.

AUTS2 EXOC3 CTIF ZFHX4 SERPINA6 YLPM1

6.53e-0743126633660365
Pubmed

Motor phenotypes and molecular networks associated with germline deficiency of Ciz1.

NR4A2 ZFHX4

3.53e-051226227163549
Pubmed

NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.

ZNF462 POGZ ZFHX4

6.24e-0510326332744500
Pubmed

Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice.

ZNF462 ZFHX4

6.41e-051626216096065
Pubmed

Human transcription factor protein interaction networks.

ZNF462 AUTS2 POGZ IKZF3 MLLT10 ZFHX4 YLPM1

6.44e-05142926735140242
Pubmed

Interaction network of human early embryonic transcription factors.

ZNF462 AUTS2 POGZ ZFHX4

1.28e-0435126438297188
Pubmed

A comprehensive negative regulatory program controlled by Brn3b to ensure ganglion cell specification from multipotential retinal precursors.

NR4A2 ZFHX4

1.35e-042326218367606
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

AUTS2 POGZ ZFHX4 GEMIN8

2.07e-0439826435016035
Pubmed

The NXSM recombinant inbred strains of mice: genetic profile for 58 loci including the Mtv proviral loci.

ITGAL GUSB

2.47e-04312622165966
Pubmed

The recombinant congenic strains--a novel genetic tool applied to the study of colon tumor development in the mouse.

ITGAL GUSB

2.97e-04342621686571
Pubmed

Genetic composition of the recombinant congenic strains.

ITGAL GUSB

4.33e-04412628903730
Pubmed

Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.

AUTS2 CTIF

6.96e-04522629455477
InteractionBOLL interactions

ATXN2L DCANP1 POGZ

1.87e-0542253int:BOLL
InteractionHAPSTR1 interactions

AUTS2 EXOC3 ATXN2L CTIF ZFHX4 SERPINA6 YLPM1

4.88e-05829257int:HAPSTR1
InteractionTLX1 interactions

ZNF462 AUTS2 POGZ ZFHX4

6.03e-05175254int:TLX1
InteractionFEV interactions

ZNF462 POGZ MLLT10 ZFHX4

1.07e-04203254int:FEV
InteractionGSC interactions

ZNF462 AUTS2 ZFHX4

1.67e-0487253int:GSC
InteractionH2BC9 interactions

DUOX2 USF3 ZFHX4 YLPM1 PHACTR1

1.91e-04446255int:H2BC9
InteractionFOXI1 interactions

ATP23 MLLT10 ZFHX4

1.97e-0492253int:FOXI1
InteractionDUXB interactions

POGZ ZFHX4

2.23e-0418252int:DUXB
CytobandEnsembl 112 genes in cytogenetic band chr2q24

NR4A2 IFIH1

2.36e-03127262chr2q24
CytobandEnsembl 112 genes in cytogenetic band chr7q11

AUTS2 GUSB

1.03e-02271262chr7q11
CytobandEnsembl 112 genes in cytogenetic band chr16p11

ATXN2L ITGAL

1.08e-02278262chr16p11
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF462 IKZF3 ZNF229 ZNF560 ZNF783

4.05e-0471817528
CoexpressionGSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN

NR4A2 IKZF3 PGLYRP1 ITGAL

2.28e-05170264M6810
CoexpressionGSE3982_EOSINOPHIL_VS_MAC_UP

NR4A2 AUTS2 POGZ ITGAL

4.06e-05197264M5401
ToppCellfacs-SCAT-Fat-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 PGLYRP1 ITGAL

2.11e-0615926451bdbacb79227fbee38bb8680c58cb99878df0c7
ToppCellCOPD-Myeloid-Mast|World / Disease state, Lineage and Cell class

ZNF462 DUOX2 IKZF3 AASS

3.61e-0618226468a1e7b804f309bfd6c23d65fad20a9a962712ae
ToppCellCOPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class

ZNF462 DUOX2 IKZF3 AASS

4.28e-06190264379dbac19110b76079a7a53209569e060a852acb
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

USF3 POGZ PHACTR1

4.49e-05119263e6f1b9f29dc8fe6b6132c7885234c385159da393
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

IKZF3 AASS ZNF783

8.24e-051462637748277cf2f12e2930d4f5a22247ab9bc266a954
ToppCellfacs-MAT-Fat-3m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

9.65e-05154263391d40ef902773ffe832a50a14d35d31c56d3723
ToppCellfacs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IKZF3 PGLYRP1 ITGAL

9.65e-051542631e088b0d4a44267f46a9b643f46a1aba784686b1
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NR4A2 ITGAL PHACTR1

9.84e-0515526377ae0b8d30bc3db4a73fd5340f99691a73d2684f
ToppCellfacs-GAT-Fat-18m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

1.06e-04159263796e63f6052189106359a4e01eae3e466bf1d593
ToppCelldroplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USF3 PGLYRP1 ITGAL

1.10e-041612633f3a2148c8d65e6a06f8d8116a3aa58dda17d618
ToppCelldroplet-Fat-Scat-18m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

1.14e-04163263b1a38985d0560dbc6ca66f711d52a208303860ca
ToppCellfacs-GAT-Fat-24m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

1.14e-04163263e58863a462cc504bced627f004a47890ee2307ce
ToppCellfacs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IKZF3 PGLYRP1 ITGAL

1.18e-04165263ab6ed7e30096c418e7be2d5eec33feeddd1387d9
ToppCellPND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IKZF3 PGLYRP1 ITGAL

1.18e-041652635f606959a060b1ae241217889560c6761ac73bbb
ToppCelldroplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NR4A2 IKZF3 PGLYRP1

1.23e-04167263cde82e3dacf347226a78873b166608b7851b34d4
ToppCelldroplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NR4A2 IKZF3 PGLYRP1

1.23e-041672636f54a699d9266c5f09ed890a11b403a6c8476fc1
ToppCellControl-Myeloid-Mast|Control / Disease state, Lineage and Cell class

ZNF462 DUOX2 IKZF3

1.29e-041702639a14deb7f7cd4a49c217eba4023f7bf1dec6c902
ToppCellControl-Myeloid-Mast|World / Disease state, Lineage and Cell class

ZNF462 DUOX2 IKZF3

1.32e-04171263ed8e61d524f4cddc6084b261175df54d2a64a60f
ToppCellfacs-Liver-Non-hepatocytes-3m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DUOX2 IKZF3 ITGAL

1.32e-04171263d322cc042a6f4b4aa8ef80ae977edbce9e266d48
ToppCelldroplet-Limb_Muscle-nan-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IKZF3 PGLYRP1 ITGAL

1.34e-04172263a3bcf0d432d8fccce50248e8d0c7a4804d69bfee
ToppCelldroplet-Limb_Muscle-nan-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IKZF3 PGLYRP1 ITGAL

1.34e-04172263976d27edd5608616830624907fe050fcd3551865
ToppCelldroplet-Kidney-nan-18m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

1.34e-041722636fc3ba9d20bae9aafe99259a7d705a1741a9294a
ToppCell368C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ZNF462 DUOX2 IKZF3

1.36e-041732638cffb4a37d30b6626188309b868ac4a62e91262f
ToppCell368C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ZNF462 DUOX2 IKZF3

1.36e-04173263fb87ea74bf70aa83b458edf728c81857c8b8eb96
ToppCellLPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NR4A2 IKZF3 ITGAL

1.38e-0417426361aa89b56ebda0eba1ba675d5f036992967f670f
ToppCellLPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NR4A2 IKZF3 ITGAL

1.41e-0417526398cb577df466700e72d1bbc6689205ccf2e7fcba
ToppCellP15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DUOX2 PGLYRP1 ZFHX4

1.41e-0417526384d252f3e432231687613299bbea14978bb4b06b
ToppCelldroplet-Kidney-nan-18m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

1.41e-0417526382d48bfade1bc2f99848b45e55c8fb0ecc999ed7
ToppCellP15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

DUOX2 PGLYRP1 ZFHX4

1.41e-04175263a00c6fa9b33640710dd05a3799031147196f0986
ToppCelldroplet-Liver-LIVER-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 PGLYRP1

1.43e-04176263dff11730f26b4b7d26ee83b665d0284bc847cac0
ToppCellControl-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class

ZNF462 DUOX2 IKZF3

1.43e-041762630c5916d63e1ada09105e46d2429b75129b7329ec
ToppCellfacs-SCAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IKZF3 PGLYRP1 ITGAL

1.46e-04177263ffc4c675b25ffe8bd3441ce26dd0984fef4b3b88
ToppCellfacs-Spleen-nan-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 PGLYRP1 ITGAL

1.46e-041772630d894a14ddbb2734557743e9efdb89cee5c26769
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

NR4A2 AUTS2 ITGAL

1.46e-0417726384930899eb2978598bc8a351cbcd9e714e46799d
ToppCelldroplet-Liver-LIVER-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 PGLYRP1

1.48e-0417826300a5d8f47373be4792bf53914db63a1aedc2d77a
ToppCellLPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NR4A2 IKZF3 ITGAL

1.51e-04179263de3ddc1264e43727be50d69b81cc84a3c91812a2
ToppCellLPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NR4A2 IKZF3 ITGAL

1.51e-04179263def981e97e3ff9019910c9af3861ca0d08eb0d0f
ToppCelldroplet-Kidney-nan-18m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 PGLYRP1 ITGAL

1.51e-0417926358be9ab455875035978c78ba7d7e4b3c9f3dc4e5
ToppCellfacs-Heart-RA-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IKZF3 PGLYRP1 ITGAL

1.53e-041802639be0af61d496a29d737bb772ad09864797994299
ToppCell11.5-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class

PGLYRP1 ITGAL PHACTR1

1.56e-04181263193ee02f547a218b2fc13e1174ea4cff4f8a3450
ToppCellfacs-Kidney-nan-24m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

1.58e-04182263e5f62ce9b9e0d28627617f7cbc81026f8442e402
ToppCellfacs-Kidney-nan-24m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

1.58e-041822630e16824c721d8b7d527157cb65feec909f6b974c
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 ZFHX4 AASS

1.58e-041822633cc61f5f7ad4a81eba3daf65e122880b5af3adc0
ToppCellAnterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 ZFHX4 AASS

1.58e-041822635d909e4b5f662905bf1be9c686bbddc3e87d2be9
ToppCellfacs-SCAT-Fat-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

1.63e-04184263f9365feed31e48f3382588bab077f99c5a3f5b04
ToppCellfacs-SCAT-Fat-18m-Lymphocytic-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

1.63e-04184263290b8ef0bc4b7b99a2b35b96a756699d3f233b96
ToppCellfacs-SCAT-Fat-18m-Lymphocytic|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 ITGAL

1.63e-0418426343313b0b4e4d4b18dd67ac0c525d7aa4db493f71
ToppCell3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NR4A2 DCANP1 ITGAL

1.66e-04185263e592c27f711d13bfc6546893acaab4c8600b0be1
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 ZFHX4 AASS

1.66e-04185263efc5d564f8793c751ba640aef60f761e4b081d3f
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 ZFHX4 AASS

1.66e-041852637aaa8335b40927e3e8fdcede807cd521fc213a0d
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 ZFHX4 AASS

1.66e-04185263fba2dc46cd98ab9c78e788959c2121aa10d148b2
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ZNF462 ZFHX4 AASS

1.66e-041852632e1766f1a972fecd670daaaf7eb2d3a404f121e7
ToppCelldroplet-Liver-LIVER-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR4A2 IKZF3 PGLYRP1

1.69e-04186263ad55da1dbb173721101126826b6db9d3434cb377
ToppCell(1)_B_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

NR4A2 IKZF3 PHACTR1

1.69e-04186263fe0f8e99ca766e004c351835fdbc2dc888dceb62
ToppCellCOPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class

ZNF462 DUOX2 IKZF3

1.69e-04186263def6f0f284acc2154738574c8c5d3d2a5ef1f208
ToppCellmild-unassigned|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

AUTS2 YLPM1 PHACTR1

1.69e-041862635b2e1a58916f392fa1156bf9210df528775248ff
ToppCell(1)_B_CD27pos|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

NR4A2 IKZF3 PHACTR1

1.71e-04187263bb189942123eb03dd6505f1af8771dd7285bb8b9
ToppCellFetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NR4A2 IKZF3 ITGAL

1.74e-041882636686dbba990066568aa7573e70a7db8b4758f457
ToppCellLPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NR4A2 IKZF3 ITGAL

1.74e-04188263bbe65b1c11c88ab62d8485cfc3a913ff9da89aad
ToppCell3'_v3-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue

AUTS2 IKZF3 ITGAL

1.77e-04189263f43bb9db7bb2d19c9849cd3ed892fe3e09e7dfe2
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

NR4A2 AUTS2 IKZF3

1.77e-041892632c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NR4A2 IKZF3 ITGAL

1.82e-04191263753deb090b7b78b4ef31604dbe5dbfc4dcf5184a
ToppCellmild_COVID-19-gd_T|mild_COVID-19 / disease group, cell group and cell class (v2)

NR4A2 AUTS2 IKZF3

1.82e-041912630e43c097b92aaa831811d60e033262999e79dcd7
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NR4A2 IKZF3 ITGAL

1.82e-04191263355f5bcb220d917163833dead0050fc756c7b260
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NR4A2 IKZF3 ITGAL

1.82e-04191263337d7d7b89fe370e1fe005b9daad76c5dc3b8444
ToppCell10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

AUTS2 IKZF3 ITGAL

1.85e-04192263e48bbcb97c113f323ad4db96bd10d593b9206923
ToppCellwk_15-18-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

NR4A2 IKZF3 ITGAL

1.85e-04192263fedff776812c3d040d295ac8c806296e4018b247
ToppCelldroplet-Mammary_Gland-nan-21m-Lymphocytic|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IKZF3 PGLYRP1 ITGAL

1.88e-04193263e1f917250478805db84a74570272b2f106993e29
ToppCell3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue

NR4A2 AUTS2 ITGAL

1.88e-04193263e790ab76c12f74a13936c231076f1e397283efb3
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

AUTS2 IKZF3 ITGAL

1.88e-04193263778fcf8448e81fe18972d97ea8a30ab036d16fe5
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-NK_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NR4A2 IKZF3 ITGAL

1.88e-04193263044fba87c4d10f4943a9f57315920280a4d097e7
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

NR4A2 AUTS2 PHACTR1

1.91e-041942635cd72330c9d9bb21b6c9d5d35085eade101486d1
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NR4A2 IKZF3 ITGAL

1.91e-04194263e3705346755cbf65fc276d4d4fbee936ed6bb7bf
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo|bone_marrow / Manually curated celltypes from each tissue

NR4A2 AUTS2 IKZF3

1.91e-04194263afbf3cecffa2c5e830ebca5db950528cc78fd269
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

AUTS2 IKZF3 ITGAL

1.91e-0419426364535db0420e53e4d777d2333b5051e63e8a3373
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

AUTS2 IKZF3 ITGAL

1.91e-04194263b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NR4A2 ITGAL PHACTR1

1.91e-04194263dfe0ece81922bfd7c6673726d3ea2365cbdb5513
ToppCell3'_v3-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue

NR4A2 AUTS2 ITGAL

1.94e-04195263731a454e45c7b610e0140312bcabaea711dcc766
ToppCell3'-Adult-LargeIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NR4A2 IKZF3 PHACTR1

1.94e-04195263daacbccf2a6a5ce1f0e3d1743a475076b4411c56
ToppCell3'_v3-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue

NR4A2 AUTS2 ITGAL

1.94e-04195263789149fb52d9d16393e1649358515add60d37f2d
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

NR4A2 AUTS2 ITGAL

1.94e-04195263730c613cf6f4d16ca51fd44de1f5a883f615c5c5
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-Cytotoxic_CD8+_T|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

NR4A2 IKZF3 ITGAL

1.97e-041962636789c88a99cadfd8122ece4b736ba6783ae6e6f5
ToppCell3'-Adult-LargeIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NR4A2 IKZF3 PHACTR1

1.97e-04196263c7363794fb731848e4343b3a4e4f800f9c81999a
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster

ZNF462 AUTS2 ZFHX4

1.97e-0419626338da0751941adca650fe9b383d9f343153978eb5
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD8|bone_marrow / Manually curated celltypes from each tissue

NR4A2 IKZF3 ITGAL

1.97e-041962635c9ed3c6e3cbd43b52f0291b5c26dd7f9fadf3da
ToppCellILEUM-inflamed-(6)_ILC-(6)_ILC1|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

NR4A2 AUTS2 IKZF3

1.97e-04196263c1d84d2e4ecc83134c3c694bed3cf035bd2742af
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster

ZNF462 AUTS2 ZFHX4

1.97e-04196263721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCellCOVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

AUTS2 IKZF3 ITGAL

2.00e-04197263836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCellmild_COVID-19_(asymptomatic)-CD8+_Tem|World / disease group, cell group and cell class (v2)

NR4A2 AUTS2 IKZF3

2.00e-04197263bdd212ea869d7c96e2ab29fa5145417afe83f2a9
ToppCell10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue

AUTS2 IKZF3 ITGAL

2.00e-0419726313e6611cde9364f0c1bf681b0b26c4d2725e5f4a
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

AUTS2 IKZF3 ITGAL

2.03e-04198263a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2
ToppCellLung_Parenchyma-Control-Myeloid-Mast_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

NR4A2 IKZF3 ZNF560

2.03e-041982630af55f2b859e4626e23e2733bf9ae2ace4547079
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

AUTS2 IKZF3 ITGAL

2.03e-04198263a781fd35a7cda8b7760c2e3ddccaac7aac26c979
ToppCellControl_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|Control_saline / Treatment groups by lineage, cell group, cell type

NR4A2 IKZF3 ITGAL

2.03e-041982639663cf0c8296d3a7b0329cb725ccceeea7849cbc
ToppCellcontrol-Lymphocytic-NK_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

AUTS2 IKZF3 ITGAL

2.03e-041982631c779101d0c5f29de5cc7170d784931d6e34bdcd
ToppCell10x5'-GI_large-bowel-Lymphocytic_T_CD8-Trm_gut_CD8|GI_large-bowel / Manually curated celltypes from each tissue

NR4A2 AUTS2 ITGAL

2.03e-04198263712f28a3cafcf209e51e9ebc2ce5013a4141bf6d
ToppCell15-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class

NR4A2 ITGAL PHACTR1

2.03e-041982630e4aa6c7d74c5b1bb26996df1be3d58f998d18ac
ToppCellmild-Lymphocytic-NK_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

AUTS2 IKZF3 ITGAL

2.03e-04198263dce3c008757786aa6bd4a869456b76b4cbbb1d5b
ToppCellKidney-Leukocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.

NR4A2 IKZF3 ITGAL

2.03e-041982634050553f292ce00d547bc79207d6b9a44f4db34f
ToppCellLung_Parenchyma-Control-Myeloid-Mast_cell-Mast_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NR4A2 IKZF3 ZNF560

2.03e-04198263f75800b4f3cf0d493226db8db7c949caade0ff90
DrugNimodipine [66085-59-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A

NR4A2 IFIH1 DUOX2 CTIF AASS

2.55e-061962656480_UP
DrugMesalamine [89-57-6]; Up 200; 26.2uM; MCF7; HT_HG-U133A

NR4A2 AUTS2 POGZ AASS ZNF783

2.82e-062002653584_UP
Drugnandrolone

SERPINA6 AASS GUSB

3.91e-0558263CID000009904
Drug2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine

SERPINA6 ITGAL

4.49e-059262ctd:C104564
DrugaMphis

ITGAL GUSB

5.61e-0510262CID000128651
DrugAstemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A

POGZ MLLT10 ITGAL YLPM1

6.34e-051922641365_DN
Drug(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A

CTIF ZFHX4 GEMIN8 PHACTR1

6.60e-051942646833_UP
DrugMoricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; HL60; HT_HG-U133A

NR4A2 ATXN2L ZNF783 YLPM1

6.60e-051942642959_UP
DrugAmiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A

NR4A2 ATXN2L CTIF GEMIN8

6.86e-051962645253_UP
DrugMethacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A

AUTS2 ATXN2L CTIF GEMIN8

6.86e-051962647321_UP
DrugAtracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A

NR4A2 IFIH1 ATXN2L ZNF783

6.86e-051962647477_DN
DrugICI182,780; Up 200; 1uM; PC3; HT_HG-U133A

IFIH1 AASS GEMIN8 ZNF783

7.00e-051972647495_UP
DrugAmikacin hydrate [37517-28-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A

NR4A2 CTIF ITGAL ZNF783

7.00e-051972643233_UP
DrugCP-319743 [172078-87-4]; Up 200; 10uM; PC3; HT_HG-U133A

NR4A2 IFIH1 ZNF783 YLPM1

7.00e-051972647491_UP
DrugRibostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A

NR4A2 ATXN2L POGZ ZNF783

7.00e-051972643444_DN
DrugClorgyline hydrochloride [17780-75-5]; Up 200; 13uM; MCF7; HT_HG-U133A

NR4A2 ATXN2L CTIF ZNF783

7.14e-051982643219_UP
DrugParomomycin sulfate [1263-89-4]; Down 200; 5.6uM; PC3; HT_HG-U133A

NR4A2 ATXN2L CTIF MLLT10

7.14e-051982644595_DN
DrugDosulepin hydrochloride [897-15-4]; Up 200; 12uM; PC3; HT_HG-U133A

IFIH1 MLLT10 GEMIN8 ZNF783

7.14e-051982647284_UP
DrugCanrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A

MLLT10 ZFHX4 ZNF783 PHACTR1

7.28e-051992646783_UP
Drug(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; PC3; HT_HG-U133A

NR4A2 CTIF ITGAL AASS

7.28e-051992644016_DN
DrugTrichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A

ATXN2L MLLT10 AASS ZNF783

7.28e-051992647287_UP
DrugDihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; PC3; HT_HG-U133A

AUTS2 IFIH1 AASS ZNF783

7.28e-051992647275_UP
DrugAntipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; PC3; HT_HG-U133A

ATXN2L CTIF AASS ZNF783

7.42e-052002644095_DN
Drughaloperidol; Up 200; 10uM; HL60; HT_HG-U133A

ATXN2L AASS ZNF783 PHACTR1

7.42e-052002642704_UP
DrugNSC98536

SERPINA6 GUSB

1.30e-0415262CID000004080
Drugluminol

DUOX2 ITGAL GUSB

1.31e-0487263CID000010638
Drugaldosterone-18-glucuronide

SERPINA6 GUSB

1.49e-0416262CID000160706
Druglormetazepam

AASS GUSB

1.90e-0418262CID000013314
Drugcannabinol

SERPINA6 GUSB

2.35e-0420262CID000002543
Drugpenicillin N

AASS GUSB

2.86e-0422262CID000071724
DrugAC1L1FH8

AASS GUSB

2.86e-0422262CID000003235
DrugmdDA

NR4A2 GUSB

2.86e-0422262CID000451450
Drug17a-methyltestosterone

SERPINA6 GUSB

3.70e-0425262CID000004160
Drugtrypanothione disulfide

SERPINA6 ITGAL AASS

5.33e-04140263CID000115098
Drugallopregnandiol

SERPINA6 GUSB

5.35e-0430262CID000004901
Drugthioacetamide

SERPINA6 AASS GUSB

5.45e-04141263CID002723949
Drugtemazepam

AASS GUSB

6.88e-0434262CID000005391
Drugthioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA

NR4A2 POGZ MLLT10

7.17e-041552631068_UP
DrugAC1L9KM8

SERPINA6 AASS

7.71e-0436262CID000447229
DrugPyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; HL60; HT_HG-U133A

NR4A2 ATXN2L POGZ

9.53e-041712632957_UP
DrugThonzonium bromide [553-08-2]; Up 200; 6.8uM; PC3; HT_HG-U133A

NR4A2 CTIF MLLT10

9.86e-041732634617_UP
DrugStrophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A

NR4A2 ATXN2L PHACTR1

1.00e-031742631302_UP
DrugFelodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A

NR4A2 IFIH1 ATXN2L

1.02e-031752633295_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

NR4A2 ATXN2L PHACTR1

1.05e-031772632678_UP
Drugthioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A

NR4A2 IFIH1 PHACTR1

1.05e-031772632690_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

NR4A2 AASS PHACTR1

1.07e-031782632685_UP
Drugcannabidiol

SERPINA6 GUSB

1.10e-0343262CID000026346
Drugprochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A

NR4A2 ZNF783 PHACTR1

1.12e-031812632675_UP
Druggeldanamycin; Up 200; 1uM; HL60; HT_HG-U133A

NR4A2 AASS PHACTR1

1.14e-031822632688_UP
DiseaseIntellectual Disability

NR4A2 ZNF462 POGZ AASS PHACTR1

3.95e-05447265C3714756
Diseasephysical activity measurement

NR4A2 AUTS2 MLLT10 PHACTR1

6.01e-05245264EFO_0008002
Diseasebody weight

NR4A2 AUTS2 ATXN2L USF3 MLLT10 GUSB PHACTR1

8.23e-051261267EFO_0004338
Diseasegrip strength measurement

AUTS2 ATXN2L MLLT10 PHACTR1

2.37e-04350264EFO_0006941
Diseasemigraine disorder

ZNF462 CTIF MLLT10 PHACTR1

2.55e-04357264MONDO_0005277
Diseaseaspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement

AUTS2 ATXN2L MLLT10 YLPM1

2.75e-04364264EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Diseasegait measurement

AUTS2 MLLT10 PHACTR1

3.07e-04150263EFO_0007680
Diseasetaste liking measurement

NR4A2 AUTS2 ATXN2L MLLT10

3.50e-04388264EFO_0010155
Diseaseinflammatory bowel disease

IFIH1 ATXN2L CTIF IKZF3

6.06e-04449264EFO_0003767
Diseaseprimary immunodeficiency disease (is_implicated_in)

IFIH1 IKZF3

6.29e-0442262DOID:612 (is_implicated_in)
Diseasesystemic lupus erythematosus (implicated_via_orthology)

IFIH1 IKZF3

6.59e-0443262DOID:9074 (implicated_via_orthology)
Diseaseselective IgA deficiency disease

IFIH1 IKZF3

7.55e-0446262EFO_1001929
Diseasebody fat percentage

AUTS2 ATXN2L MLLT10 YLPM1

8.28e-04488264EFO_0007800
Diseaseneuroticism measurement, cognitive function measurement

AUTS2 ATXN2L MLLT10 YLPM1

1.43e-03566264EFO_0007660, EFO_0008354
Diseasesynophrys measurement

AUTS2 ZFHX4

1.64e-0368262EFO_0007906
Diseaseresponse to selective serotonin reuptake inhibitor

AUTS2 PHACTR1

2.37e-0382262EFO_0005658
Diseasemigraine disorder, Headache

ZNF462 PHACTR1

2.61e-0386262HP_0002315, MONDO_0005277
Diseasesmoking status measurement

AUTS2 CTIF ATP23 MLLT10 PHACTR1

3.07e-031160265EFO_0006527
Diseaseulcerative colitis

IFIH1 CTIF IKZF3

3.11e-03335263EFO_0000729
Diseaseplatelet-to-lymphocyte ratio

AUTS2 IKZF3 ITGAL

3.89e-03363263EFO_0008446
Diseasevital capacity

AUTS2 ATXN2L CTIF MLLT10 GUSB

4.04e-031236265EFO_0004312

Protein segments in the cluster

PeptideGeneStartEntry
MHYGAATHIQNSRSH

DCANP1

1

Q8TF63
HHGYSQNRRWHHGNM

CTIF

241

O43310
HIGMAHNYRNSSQAV

AASS

181

Q9UDR5
YAIHHQQLPHGFTNM

ATXN2L

946

Q8WWM7
NNIHNQAHMNRVVTH

ATP23

111

Q9Y6H3
QHYHQAMAWMQSHHN

GEMIN8

26

Q9NWZ8
QLVNRQDRAHFMHHY

DUOX2

1531

Q9NRD8
ASCQQQARNVQHYHM

PGLYRP1

71

O75594
AMHVHIAWQIYHHQQ

AUTS2

651

Q8WXX7
SQIQHQLQYGSHGQH

PHACTR1

281

Q9C0D0
QFFNNVSLHHHMQVM

GUSB

416

P08236
HHTNKEAVYNNIMRH

IFIH1

446

Q9BYX4
HLRNRQHPHCYVQYM

EXOC3

476

O60645
RQNHIYQQNHMVLSR

IKZF3

396

Q9UKT9
NAAYVNMSNHHRGLA

SERPINA6

26

P08185
KVEDIQMHNYQQHSH

NR4A2

91

P43354
QMHNYQQHSHLPPQS

NR4A2

96

P43354
GNAFQQHYMRHQKRN

POGZ

631

Q7Z3K3
HMYQVRIQPSIHDHN

ITGAL

951

P20701
EQHQAFLYQLMQHHH

MLLT10

986

P55197
FLYQLMQHHHQQHHQ

MLLT10

991

P55197
HQHMHFLAAQNQFLH

ZFHX4

2466

Q86UP3
QLRERHHLYQMQHHV

USF3

1481

Q68DE3
QQYKHQMLHHQRDGP

YLPM1

121

P49750
NSYLQAHQRVHMGQH

ZNF229

501

Q9UJW7
AHQRVHMGQHLYKCN

ZNF229

506

Q9UJW7
LQQHYGEHHPEAMNV

ZNF462

901

Q96JM2
DFRYPTHLNNHMQTH

ZNF560

356

Q96MR9
NHHLAVHMQTHARGQ

ZNF783

506

Q6ZMS7